Mobile Cardiac Telemetry Devices Market: Current Scenario and Forecast (2019-2025)

$3500$6860

Emphasis on Technology (Lead-Based, Patch Based), End-Users (Hospitals, Ambulatory Surgical Centres, Home Setting) and Region/Country

Published:

Nov-2019

Pages:

231

Table:

86

Figure:

136

Report ID:

UMHE19189

Geography:

Clear
  Get a Free Sample
SKU: UMHE19189 Categories: ,
Report Description
Table of content
Research Methodology

Report Description

Global Mobile Cardiac Telemetry Devices was valued at US$ 563.7 million in 2018 and is anticipated to reach US$ 1,264 million by 2025 displaying a reasonable CAGR of 12.34% over the forecast period (2019-2025). Increasing prevalence of cardiovascular diseases, rising geriatric population, increasing medical tourism in emerging nations are the key growth drivers for global mobile cardiac telemetry devices market. Interoperability and wireless technology to enhance real-time, remote monitoring, and transition of care delivery from hospital to home are also stimulating market growth globally. However, clinical effectiveness, the need for validation, cost effectiveness and data security are the major restraining factors for the market growth. Mobile Cardiac Telemetry is becoming more and more common as the device is far less labour intensive for the patient as compared to the traditional Event Monitor. The monitoring is the wave of the future because there are so many technological advantages compared to other long-term monitoring options. MCT monitoring technology can be considered a superior method for detecting ECG abnormalities as it captures cardiac abnormalities in real time. The expedited nature of MCT can potentially improve diagnostic care and lower healthcare costs over the long run.

In recent years the prevalence of chronic diseases has increased due to the rise in life expectancy and changes in lifestyle, and thus people suffering from these pathologies often need continuous monitoring of their vital signs. The mobile health field can provide new access opportunities for treatment and medical services, constituting a valuable support instrument for both patients and doctors. Mobile cardiac telemetry (MCT) is a relatively new technology, first approved in 2002 by the US Food and Drug Administration (FDA), which provides continuous real-time outpatient electrocardiographic monitoring for extended periods of time. MCT allows the detection of both symptomatic and asymptomatic arrhythmias and has been proven to provide superior diagnostic capability for patients with palpitations, syncope, and pre-syncope. It also allows accurate monitoring of a patient’s rhythm during outpatient drug titration, as well as detection of both symptomatic and asymptomatic atrial fibrillation after cardiac ablation.

“Lead based MCT devices held the largest market share 60.2% in 2018”

Based on technology type, the global Mobile Cardiac Telemetry Devices market is bifurcated into Lead based and Patch based devices. Lead based devices dominated the market in 2018, with the maximum share in terms of revenue and are expected to maintain its dominance throughout the forecast period, owing to its increased application in high-end vehicles. Patch based devices, on the other hand, is expected to register the fastest growth during the forecast period.

Mobile Cardiac Telemetry Devices Market Size by Technology, Global, 2018-25 (US$ Mn)

“Hospitals are the major adopter of Mobile Cardiac Telemetry Devices technology”

Hospitals, Ambulatory Surgical Centers and Home Settings are the major end-users considered in the global Mobile Cardiac Telemetry Devices market study. Hospitals are the major end-users of mobile telemetry device technology; the segment generated a revenue of US$ 350.5 million in 2018. The hospital’s end-user segment is expected to grow at a CAGR of 11.67% during the forecast periodHowever, the home setting is expected to witness highest CAGR during the 2019-2025 period.

“Europe dominated the global Mobile Cardiac Telemetry Devices market in 2018”

Also, for better understanding of the overall adoption rate of mobile cardiac telemetry devices in different developed and developing markets, detailed analysis has been conducted for different regions/countries including North America (US, Canada), Europe (UK, Germany, France, Spain, Italy), Asia-Pacific (China, India, Japan, Australia), and the Rest of the World (Middle East and Latin America). Based on the estimation, Europe dominated the Mobile Cardiac Telemetry devices market, accounting for a revenue share of 31.9% in 2018. The rising incidence of cardiovascular diseases in Europe is influencing the healthcare service providers to implement advanced telehealth services. Hence, the increasing usage of telecardiology is expected to drive the market.

Competitive Landscape-Top 10 Market Players

Asahi Kasei Corp., BioTelemetry Inc., Biotricity, Comarch, Hill-Rom Holdings Inc, Infobionic, Koninklijke Philips N.V., Medicalgorithmics, Medicomp and Preventice are some of the prominent players operating in the global Mobile Cardiac Telemetry Devices industry. These players are adopting several growth strategies including acquisition, product launches, partnership and business expansion to increase their market presence and benefit as first mover advantages. The industry has also witnessed the emergence of several start-ups in the respective domain, majorly in the European region.

Reasons to buy (The research report presents):

  • Current and future market size from 2018 to 2025 in terms of value (US$)
  • Combined analysis of deep dive secondary research and input from primary research through Key Opinion Leaders of the industry
  • Country level details of the overall adoption of MCT devices in major healthcare facilities and current and future health status of the country
  • A quick review of overall industry performance at a glance
  • In-depth analysis of key industry players
  • A detailed analysis of regulatory framework, drivers, restraints, key trends and opportunities prevailing in the industry
  • Examination of industry attractiveness with the help of Porter’s Five Forces analysis and start ups
  • The study comprehensively covers the market across different segments and sub-segments of the technology
  • Region/country Covered: North America (US, Canada), Europe (UK, Germany, France, Spain, Italy), Asia-Pacific (China, India, Japan, Australia), and the Rest of the World

Customization Options:

UMI understands that you may have your own business need, hence we also provide fully customized solutions to clients. The Global Mobile Cardiac Telemetry Devices Market can be customized to country level or any other market segment.

1.1 Market Definition
1.2 Objective of the Study
1.3 Limitation
1.4 Stakeholders
1.5 Currency used in the Report
1.6 Scope of the Global Mobile Cardiac Telemetry Devices Market Study

2RESEARCH METHODOLOGY OR ASSUMPTION
  2.1Research Methodology for Global Mobile Cardiac Telemetry Devices Market Study
   2.1.1Main objective of the Global Mobile Cardiac Telemetry Devices Market Study

Key Facts on Cardiovascular diseases (CVDs), Global

6.1General Overview
   6.1.1Holter Monitoring reimbursement
   6.1.2Mobile Cardiac Telemetry Reimbursement
   6.1.3Cardiac Event Monitoring Reimbursement
  6.2Medicare National Coverage
  6.32017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/ telemetry
   6.3.1Reimbursement
   6.3.2Reimbursement in Europe
7.1General Overview
  7.2Criteria/Guidelines
  7.3Criteria/Guidelines
  7.4Limitations 
  7.5Administrative Guidelines
  7.6Observational Study
  7.7Practice Guidelines and Position Statements
  7.8Telemetry Devices to Monitor Cardiac Patients: Safety and Guidelines in Canada
  7.9The legal framework in regulating remote (cardiac) monitoring in France
  7.1The legal framework in regulating remote (cardiac) monitoring in Italy
8.1Demand Side Analysis
  8.2Supply Side Analysis
   8.2.1Top Product Launches under Mobile Cardiac Telemetry Devices
   8.2.2Top Partnerships under Mobile Cardiac Telemetry Devices
   8.2.3Top Mergers & Acquisitions under Mobile Cardiac Telemetry Devices
   8.2.4Top Business Expansion & Investment under Mobile Cardiac Telemetry Devices
9.1Value Chain Analysis
10.1General Overview
   10.1.1Lead-Based MCT Device
    10.1.1.1Case Study 1- Superiority of MCT Devices
   10.1.2Patch Based MCT Device
    10.1.2.1Case study 2- Superiority of MCT Devices
11.1General Overview
   11.1.1Hospitals 
    11.1.1.1Case Study 3- Superiority of MCT Devices
   11.1.2Ambulatory Surgical Centres
    11.1.2.1Case study 4- Superiority of MCT Devices
   11.1.3Home Setting
    11.1.3.1Case Study 5-Cost-Effectiveness of Mobile Cardiac Telemetry
12.1General Overview
  12.2North America Mobile Cardiac Telemetry Devices Market (2019-2025)
   12.2.1North America MCT Devices Market by Technology
   12.2.2North America Mobile Cardiac Telemetry Devices Market by End-User
   12.2.3North America Mobile Cardiac Telemetry Devices Market by Country
    12.2.3.1United States Mobile Cardiac Telemetry Devices Market (2019-2025)
     12.2.3.1.1Facts on Heart Disease in the US
     12.2.3.1.2Facts on Coronary Heart Disease (CHD) in the US
     12.2.3.1.3Facts on Stoke in the US
     12.2.3.1.4US Mobile Cardiac Telemetry Devices Market by Technology
     12.2.3.1.5US Mobile Cardiac Telemetry Devices Market by End-User
    12.2.3.2Canada Mobile Cardiac Telemetry Devices Market (2018-2025)
     12.2.3.2.1Facts on heart disease in Canada
     12.2.3.2.2Canada Mobile Cardiac Telemetry Devices Market by Technology
     12.2.3.2.3Canada Mobile Cardiac Telemetry Devices Market by End-User
    12.2.3.3Rest of North America Mobile Cardiac Telemetry Devices Market (2018-2025)
     12.2.3.3.1Rest of NA Mobile Cardiac Telemetry Devices Market by Technology
     12.2.3.3.2Rest of NA Mobile Cardiac Telemetry Devices Market by End-User
  12.3Europe Mobile Cardiac Telemetry Devices Market (2018-2025)
   12.3.1Facts on Cardiovascular Disease in Europe
   12.3.2Europe Mobile Cardiac Telemetry Devices Market by Technology
   12.3.3Europe Mobile Cardiac Telemetry Devices Market by End-User
   12.3.4Europe Mobile Cardiac Telemetry Devices Market by Country
    12.3.4.1France Mobile Cardiac Telemetry Devices Market (2019-2025)
     12.3.4.1.1France Mobile Cardiac Telemetry Devices Market by Technology
     12.3.4.1.2France Mobile Cardiac Telemetry Devices Market by End-User
    12.3.4.2Germany Mobile Cardiac Telemetry Devices Market (2018-2025)
     12.3.4.2.1Germany Mobile Cardiac Telemetry Devices Market by Technology
     12.3.4.2.2Germany Mobile Cardiac Telemetry Devices Market by End-User
    12.3.4.3Sweden Mobile Cardiac Telemetry Devices Market (2018-2025)
     12.3.4.3.1Sweden Mobile Cardiac Telemetry Devices Market by Technology
     12.3.4.3.2Sweden Mobile Cardiac Telemetry Devices Market by End-User
    12.3.4.4Netherlands Mobile Cardiac Telemetry Devices Market (2018-2025)
     12.3.4.4.1Netherlands Mobile Cardiac Telemetry Devices Market by Technology
     12.3.4.4.2Case Study-Cost effectiveness of home telemonitoring (HTM) and nurse telephone support (NTS)
     12.3.4.4.3Netherlands Mobile Cardiac Telemetry Devices Market by End-User
    12.3.4.5Italy Mobile Cardiac Telemetry Devices Market (2018-2025)
     12.3.4.5.1Italy Mobile Cardiac Telemetry Devices Market by Technology
     12.3.4.5.2Italy Mobile Cardiac Telemetry Devices Market by End-User
    12.3.4.6United Kingdom Mobile Cardiac Telemetry Devices Market (2018-2025)
     12.3.4.6.1United Kingdom Mobile Cardiac Telemetry Devices Market by Technology
     12.3.4.6.2United Kingdom Mobile Cardiac Telemetry Devices Market by End-User
    12.3.4.7Rest of Europe Mobile Cardiac Telemetry Devices Market (2018-2025)
     12.3.4.7.1Rest of Europe Mobile Cardiac Telemetry Devices Market by Technology
     12.3.4.7.2Rest of Europe Mobile Cardiac Telemetry Devices Market by End-User
  12.4Asia Pacific Mobile Cardiac Telemetry Devices Market (2018-2025)
   12.4.1Asia Pacific Mobile Cardiac Telemetry Devices Market by Technology
   12.4.2Asia Pacific Mobile Cardiac Telemetry Devices Market by End-User
   12.4.3Asia Pacific Mobile Cardiac Telemetry Devices Market by Country
    12.4.3.1Japan Mobile Cardiac Telemetry Devices Market (2018-2025)
     12.4.3.1.1Japan Mobile Cardiac Telemetry Devices Market by Technology
     12.4.3.1.2Japan Mobile Cardiac Telemetry Devices Market by End-User
    12.4.3.2China Mobile Cardiac Telemetry Devices Market (2018-2025)
     12.4.3.2.1China Mobile Cardiac Telemetry Devices Market by Technology
     12.4.3.2.2China Mobile Cardiac Telemetry Devices Market by End-User
    12.4.3.3India Mobile Cardiac Telemetry Devices Market (2018-2025)
     12.4.3.3.1India Mobile Cardiac Telemetry Devices Market by Technology
     12.4.3.3.2India Mobile Cardiac Telemetry Devices Market by End-User
    12.4.3.4Rest of Asia Pacific Mobile Cardiac Telemetry Devices Market (2018-2025)
     12.4.3.4.1Rest of APAC Mobile Cardiac Telemetry Devices Market by Technology
     12.4.3.4.2Rest of APAC Mobile Cardiac Telemetry Devices Market by End-User
  12.5Rest of World Mobile Cardiac Telemetry Devices Market (2018-2025)
   12.5.1Rest of World Mobile Cardiac Telemetry Devices Market by Technology
   12.5.2Rest of World Mobile Cardiac Telemetry Devices Market by End-User
   12.5.3Rest of World Mobile Cardiac Telemetry Devices Market by Country
    12.5.3.1South Africa Mobile Cardiac Telemetry Devices Market (2018-2025)
     12.5.3.1.1South Africa Mobile Cardiac Telemetry Devices Market by Technology
     12.5.3.1.2South Africa Mobile Cardiac Telemetry Devices Market by End-User
    12.5.3.2Brazil Mobile Cardiac Telemetry Devices Market (2018-2025)
     12.5.3.2.1Brazil Mobile Cardiac Telemetry Devices Market by Technology
     12.5.3.2.2Brazil Mobile Cardiac Telemetry Devices Market by End-User
    12.5.3.3Other Countries Mobile Cardiac Telemetry Devices Market (2018-2025)
     12.5.3.3.1Other RoW Mobile Cardiac Telemetry Devices Market by Technology
     12.5.3.3.2Other RoW Mobile Cardiac Telemetry Devices Market by End User
13.1Porter’s Five forces analysis
   13.1.1Bargaining power of the Supplier
   13.1.2Bargaining power of Buyer
   13.1.3Industry Rivalry
   13.1.4Availability of Substitute
   13.1.5Threat of New Entrants
  13.2Market Share Analysis, by Company 2018
   13.2.1Some Major agreements of BioTelemetry
   13.2.2Market Share of Key Players in Mobile Cardiac Telemetry Devices, 2018
14.1Asahi Kasei Corporation
   14.1.1Key Facts 
   14.1.2Business Description
   14.1.3Key Product/Services Offerings
   14.1.4Growth Strategy
   14.1.5SWOT Analysis
   14.1.6Key Financials
    14.1.6.1Revenue Split
   14.1.7Recent Developments
    14.1.7.1Product Launches
    14.1.7.2Partnerships
    14.1.7.3Mergers and Acquisitions
  14.2BioTelemetry Inc.
   14.2.1Key Facts 
   14.2.2Business Description
   14.2.3Key Product/Services Offerings
   14.2.4Growth Strategy
   14.2.5SWOT Analysis
   14.2.6Key Financials
    14.2.6.1Revenue Split
   14.2.7Recent Developments
    14.2.7.1Partnerships (Strategic Alliance)
    14.2.7.2Mergers and Acquisitions
  14.3Biotricity  
   14.3.1Key Facts 
   14.3.2Business Description
   14.3.3Key Product/Services Offerings
   14.3.4Growth Strategy
   14.3.5SWOT Analysis
   14.3.6Key Financials
   14.3.7Recent Developments
    14.3.7.1Product Launch
    14.3.7.2Business Expansion and Investment
  14.4Comarch  
   14.4.1Key Facts 
   14.4.2Business Description
   14.4.3Key Product/Services Offerings
   14.4.4Growth Strategy
   14.4.5SWOT Analysis
   14.4.6Key Financials
    14.4.6.1Revenue Split
   14.4.7Recent Developments
    14.4.7.1Partnership
    14.4.7.2Business Expansion & Investments
  14.5Hill-Rom Holdings Inc
   14.5.1Key Facts 
   14.5.2Business Description
   14.5.3Key Product/Services Offerings
   14.5.4Growth Strategy
   14.5.5SWOT Analysis
   14.5.6Key Financials
    14.5.6.1Revenue Split
   14.5.7Recent Developments
    14.5.7.1Product Launches
    14.5.7.2Partnership
    14.5.7.3Expansions and Investments
    14.5.7.4Mergers and Acquisitions
  14.6Infobionic 
   14.6.1Key Facts 
   14.6.2Business Description
   14.6.3Key Product/Services Offerings
   14.6.4Growth Strategy
   14.6.5SWOT Analysis
   14.6.6Recent Developments
    14.6.6.1Product Launch
    14.6.6.2Business Expansion and Investment
  14.7Koninklijke Philips N.V.
   14.7.1Key Facts 
   14.7.2Business Description
   14.7.3Key Product/Services Offerings
   14.7.4SWOT Analysis
   14.7.5Key Financials
    14.7.5.1Revenue Split
   14.7.6Recent Developments
    14.7.6.1Product Launches
    14.7.6.2Partnership
    14.7.6.3Merger and Acquisition
  14.8Medicalgorithmics
   14.8.1Key Facts 
   14.8.2Business Description
   14.8.3Key Product/Services Offerings
   14.8.4SWOT Analysis
   14.8.5Key Financials
    14.8.5.1Revenue Split
   14.8.6Recent Developments
    14.8.6.1Product Launch
    14.8.6.2Partnerships
    14.8.6.3Business Expansions and Investments
    14.8.6.4Merger & Acquisitions
  14.9Medicomp 
   14.9.1Key Facts 
   14.9.2Business Description
   14.9.3Key Product/Services Offerings
   14.9.4SWOT Analysis
   14.9.5Recent Developments
   14.9.5.1Product Launches
  14.10Preventice Solutions
   14.10.1Key Facts 
   14.10.2Business Description
   14.10.3Key Product/Services Offerings
   14.10.4SWOT Analysis
   14.10.5Recent Developments
    14.10.5.1Product Launches

Research Methodology

Analyzing historical market, estimation of the current market and forecasting the future market for Global Mobile Cardiac Telemetry Devices were the three major steps undertaken to create and analyze the overall adoption rate of the technology/service in major regions/countries. Exhaustive secondary research was done to collect the historical market and overall estimation of the current market of the technology. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were conducted with industry experts across value chain of the Mobile Cardiac Telemetry Devices market. Post all the assumptions and validation of market numbers through primary interviews, top-down approach was employed to forecast the complete market size of the technology. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the technology. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the Global Mobile Cardiac Telemetry Devices Market through company internal sources such as annual report & financial statements, performance presentations, press releases, inventory records, etc. and external sources including trade journals, news & articles, government publications, economic data, competitor publications, sector reports, regulatory bodies publications, safety standard organizations, third-party database and other creditable publicationsFor economic data collection, sources such as World Bank, CDC, European Commission (EC), United Nations and WHO, OECD among others were used.

Step 2: Market Segmentation:

After obtaining the historical market size of the overall market, detailed secondary analysis was conducted to gather historical market insights and share for different segments and sub-segment of the Mobile Cardiac Telemetry Devices market. Major segments included in the report are technology and end-users.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments detailed factor analysis was conducted to estimate the current market size of the Global Mobile Cardiac Telemetry Devices. Factor analysis was conducted using dependent and independent variables including accelerating aging population, rising prevalence of cardiovascular diseases and rising geriatric population. Historical trends of the Global Mobile Cardiac Telemetry Devices and their year-on-year impact on the market size and share in the recent past were analyzed. The demand and supply side scenario were also thoroughly studied.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on the actionable insights from the above 3 steps, we arrived at current market size, key players in major applications and markets, market shares of these players and industry’s supply chain. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weightage was assigned to different factors including market drivers, restraints, trends and opportunities available in the market. After analyzing these factors, relevant forecasting techniques i.e. Bottom-up/Top-down was applied to arrive at the market forecast pertaining to 2025 for different segments and sub-segments in different regions/countries. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of value and rate of adoption of Mobile Cardiac Telemetry Devices
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in major applications and markets as well as the market share of each player. Also, the growth strategies adopted by these players to compete in the ever-growing Global Mobile Cardiac Telemetry Devices market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, etc.). Primary research findings were summarized, and statistical analysis was performed to prove the stated hypothesis. Input from primary research was consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants

Market Engineering

Data triangulation technique was employed to complete the overall market engineering process and to arrive precise statistical numbers of each segment and sub-segment pertaining to the Global Mobile Cardiac Telemetry Devices market. Data was split into several segments post studying various parameters and trends in the areas of technology such as lead-based, patch based and end-users (hospitals, ambulatory surgical centers, home settings) and regions including North America, Europe, Asia-Pacific and Rest of the World

Main objective of the Mobile Cardiac Telemetry Devices Market Study

The current & future market trends of the global mobile cardiac telemetry devices are pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends would determine the overall attractiveness of the market not only at regional but also at the country level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the study include:

  • Analyze the current and future market size of the Global Mobile Cardiac Telemetry Devices Market in terms of value (US$). In addition, analyze the current and forecast market size of different segments and sub-segments
  • Segments in the study include components, applications and region/country
  • Analyze the value chain involved in the industry along with the presence of various intermediaries along with the customer and competitor analysis, etc.
  • Define and analysis of the government regulations for the Mobile Cardiac Telemetry devices in major countries
  • Analyze the current and forecast market size of the Global Mobile Cardiac Telemetry Devices Market, in terms of value for regions/countries including North America (US, Canada), Europe (France, Spain, Italy, UK, Germany), Asia-Pacific (India, China, Japan) and Rest of the World (Middle East and Latin America)
  • Define and analyze the competitive landscape of the Global Mobile Cardiac Telemetry Devices Market and the growth strategies adopted by these players to sustain in the ever-growing market